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Abstract
Background: Many people believe in favourable effects of branched-chain amino acids (BCAAs; valine, leucine, and
isoleucine), especially leucine, on muscle protein balance and consume BCAAs for many years. We determined the
effects of the chronic intake of a BCAA- or leucine-enriched diet on protein and amino acid metabolism in fed and
postabsorptive states.
Methods: Rats were fed a standard diet, a diet with a high content of valine, leucine, and isoleucine (HVLID), or a
high content of leucine (HLD) for 2 months. Half of the animals in each group were sacrificed in the fed state on
the last day, and the other half were sacrificed after overnight fast. Protein synthesis was assessed using the
flooding dose method (L-[3,4,5-3H]phenylalanine), proteolysis on the basis of chymotrypsin-like activity (CHTLA) of
proteasome and cathepsin B and L activities.
Results: Chronic intake of HVLID or HLD enhanced plasma levels of urea, alanine and glutamine. HVLID also
increased levels of all three BCAA and branched-chain keto acids (BCKA), HLD increased leucine, ketoisocaproate
and alanine aminotransferase and decreased valine, ketovaline, isoleucine, ketoisoleucine, and LDL cholesterol.
Tissue weight and protein content were lower in extensor digitorum longus muscles in the HLD group and higher
in kidneys in the HVLID and HLD groups. Muscle protein synthesis in postprandial state was higher in the HVLID
group, and CHTLA was lower in muscles of the HVLID and HLD groups compared to controls. Overnight starvation
enhanced alanine aminotransferase activity in muscles, and decreased protein synthesis in gastrocnemius (in HVLID
group) and extensor digitorum longus (in HLD group) muscles more than in controls. Effect of HVLID and HLD on
CHTLA in muscles in postabsorptive state was insignificant.
Conclusions: The results failed to demonstrate positive effects of the chronic consumption of a BCAA-enriched diet
on protein balance in skeletal muscle and indicate rather negative effects from a leucine-enriched diet. The primary
effects of both diets are an activated catabolism of BCAAs, which leads to an enhanced production of BCKA,
alanine and glutamine and their utilization in visceral tissues and an impaired protein synthesis in postabsorptive
state, particularly in fast-twitch (white) muscles.
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Background
The branched-chain amino acids (BCAAs) valine, leu-
cine and isoleucine are essential substrates and import-
ant regulators in the synthesis of body proteins,
substrates for energy production and precursors for the
formation of other amino acids. The stimulatory effect
of BCAAs on protein synthesis and the inhibitory effect
on proteolysis have been known for many years [1–3].
Particularly, leucine was implicated in the stimulation of
protein synthesis in skeletal muscle. Leucine enhances
insulin release from β-cells of the pancreas and directly
stimulates protein synthesis through the mammalian tar-
get of rapamycin (mTOR) signalling pathway and the
phosphorylation of translation initiation factors and
ribosomal proteins [4, 5]. The inhibitory effect of
BCAAs on proteolysis is likely mediated by several me-
tabolites of BCAAs, particularly branched-chain keto
acids and beta-hydroxy-beta-methylbutyrate [6, 7].
The initial site for most BCAA catabolism is skeletal
muscle because of the high activity of BCAA amino-
transferase, which enables the transfer of the amino
group of BCAAs to α-ketoglutarate to form glutamate
and branched-chain keto acids (BCKA), i.e., α-
ketoisocaproate (KIC, ketoleucine), α-keto-β-methylvale-
rate (KMV, ketoisoleucine) and α-ketoisovalerate (KIV,
ketovaline). The enhanced availability of glutamic acid
increases the flux through glutamine synthetase and ala-
nine aminotransferase leading to enhanced synthesis of
glutamine and alanine. These amino acids are released
together with most of the BCKA from skeletal muscle to
the blood [8–10]. Overall, an enhanced intake of BCAAs
should lead to enhanced BCAA catabolism and the re-
lease of glutamine, alanine and BCKA from muscles to
the blood stream (Fig. 1).
The unique effects of BCAAs on protein metabolism
led to the use of BCAAs in patients with cachectic disor-
ders and as popular dietary supplements, especially in
athletes. However, chronic and excessive intake of the
BCAAs raises concerns of their adverse side effects. The
chronic intake of high amounts of BCAAs may induce
an imbalance in amino acid concentrations in body
fluids, alter various biochemical pathways and cellular
functions, and the response of the body to different
physiological and pathological conditions, such as star-
vation, exercise, trauma, infection, and cancer develop-
ment. Unfortunately, few studies have investigated the
long-term effects of BCAA supplementation, and there
is a lack of information on the side effects and conse-
quences of the long-term intake of these supplements.
We determined how the chronic intake of a BCAA- or
leucine-enriched diet affected protein and amino acid
homeostasis, particularly the effect on protein balance in
skeletal muscle and on the concentrations of free amino
acids in extracellular and intracellular spaces, especially
BCAA, alanine, and glutamine levels. Various types of
hindlimb muscles were examined, including m. soleus
(SOL, slow-twitch, red muscles), m. extensor digitorum
longus (EDL, fast-twitch, white muscle), and m. gastro-
cnemius (GM, both fibre types), because of reported dif-
ferences in protein, BCAA and glutamine metabolism in
slow-twitch and fast-twitch muscles [11–13].
The effects of BCAA- or leucine-enriched diet have
been examined in two nutritionally different condition-
s—in fed and overnight fasted animals. In fed (postpran-
dial) state are concentrations of nutrients in body fluids
closely related to composition of the food and anabolic
response of the body mediated by enhanced secretion of
insulin. After overnight fast (in postabsorptive state) is
the effect of food composition on concentration of nutri-
ents in extracellular fluid smaller and the main role play
gradual decrease in insulin/glucagon ratio and enhanced
catabolism of glycogen, lipids, and proteins.
Methods
Animals and material
Male Wistar rats (BioTest, Konarovice, CR) were housed
in standardised cages in quarters with controlled
temperature and a 12-h light–dark cycle. All rats re-
ceived the standard laboratory diet (SLD) ST-1 (Velas,
CR) and drinking water ad libitum. All procedures
Fig. 1 The primary pathways of BCAA catabolism in skeletal muscle and the supposed response of skeletal muscle and liver to surplus exogenous
BCAAs. 1, BCAA aminotransferase; 2, BCKA dehydrogenase; 3, glutamine synthetase; 4, alanine aminotransferase (ALT)
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involving animals were performed according to the
guidelines set by the Institutional Animal Care and Use
Committee of Charles University. Animal Care and Use
Committee of Charles University in Prague, Faculty of
Medicine in Hradec Kralove specifically approved this
study. L-[3,4,5-3H]phenylalanine was purchased from
American Radiolabeled Chemical, Inc. (St. Louis, MO,
USA). Chemicals were obtained from Sigma Chemical
(St. Louis, MO, USA), Lachema (Brno, CR), Waters
(Milford, MA, ISA), Biomol (Hamburg, Germany), and
Merck (Darmstadt, Germany).
Experimental design
A total of 120 male Wistar rats weighing approximately
200 g each were randomly divided into three groups fed
an SLD or a diet in which 10 % of the basal diet was re-
placed by a mixture of valine, leucine, and isoleucine in
ratios of 1 : 1 : 1 (HVLID, high valine, leucine, and iso-
leucine diet) or leucine (HLD, high leucine diet). The
mixtures were used to prepare pellets with the same
physical properties and consistency. Estimated contents
of L-valine, L-leucine, and L-isoleucine (g/kg diet) are
shown in Table 1. These contents resemble a high-dose
supplementation in which adverse outcomes for the
monitored variables were not reported [14–16].
The animals consumed tested diets for 2 months and
were sacrificed between 7 and 8 a.m. on the last day of
the study protocol. Half of the animals in each group
were sacrificed in the fed state, and the other half were
sacrificed after an overnight fast. Two separate studies
were performed. Tissue protein synthesis rates were
measured using the flooding dose method (L-[3,4,5-
3H]phenylalanine) in the first study. Alterations in amino
acid concentrations in body fluids and various parame-
ters of protein and amino acid metabolism were esti-
mated in the second study.
Protein synthesis
The rats were injected intravenously with a flooding
dose of L-[3,4,5-3H]phenylalanine (50 μCi/100 g b.w.)
combined with unlabelled L-phenylalanine (150 μmol/
100 g b.w.) 10 min before the sacrifice by exsanguination
via the abdominal aorta [17]. Small pieces (approxi-
mately 0.1 g) of soleus (SOL), gastrocnemius (GM), and
extensor digitorum longus (EDL) muscles, liver, kidneys,
and jejunum were quickly removed and frozen in liquid
nitrogen. Tissue samples were homogenized in 6 % (v/v)
perchloric acid, and the precipitated proteins were col-
lected via centrifugation for 5 min at 12,000 g. The
supernatant was used for the measurement of L-[3,4,5-
3H]phenylalanine specific activity. The pellet was washed
three times and hydrolysed in 2 N NaOH. Aliquots were
taken for protein content [18] and radioactivity measure-
ments. The fractional rate of protein synthesis (FRPS)
was calculated according the formula derived by McNur-
lan et al. [19]:
FRPS % per dayð Þ ¼ Sb⋅100ð Þ= t⋅Sað Þ
where Sb and Sa are the specific activities (dpm/nano-
mole) of protein-bound phenylalanine and tissue-free
phenylalanine in the acid-soluble fraction of tissue ho-
mogenates, respectively, and t is the time (days) between
isotope injection and tissue immersion into liquid nitro-
gen. The value of 274 μmol phenylalanine/g protein was
used for the calculation of protein-bound phenylalanine
specific activity [20]. Sample radioactivity was measured
using a liquid scintillation radioactivity counter LS 6000
(Beckman Instruments, Fullerton, CA, USA).
Amino acid concentrations in blood plasma and tissues
Amino acid concentrations were determined in the su-
pernatants of deproteinised blood plasma and tissue
samples using high-performance liquid chromatography
(Aliance 2695, Waters, Milford, MA, USA) after deriva-
tisation with 6-aminoquinolyl-N-hydroxysuccinimidyl
carbamate. The intracellular concentration of each
amino acid was calculated by subtracting the free extra-
cellular portion from the total amount, assuming the
plasma concentration to be equal to the concentration
in the interstitial fluid as described by Bergstrőm et al.
[21]. Total tissue water was measured from the tissue
weight obtained after drying for 24 h at 90 °C. The de-
termination of extra- and intracellular water was based
on the chloride method according to Graham et al. [22].
BCKA concentrations in blood plasma were measured
using liquid chromatograph (Shimadzu, Kyoto, Japan)
after precolumn derivatisation with o-phenylenediamine
[23].
Chymotrypsin-like activity (CHTLA)
The chymotrypsin-like activity of proteasomes was de-
termined using the fluorogenic substrate Suc-LLVY-
MCA [24] as follows. The muscles were homogenised in
0.4 ml of ice-cold 20 mM Tris buffer, pH 7.5, containing
2 mM ATP, 5 mM MgCl2 and 1 mM dithiothreitol. The
homogenates were centrifuged for 10 min at 18,000 g at
4 °C. Cellular supernatants (0.1 ml) were incubated with
0.1 ml of substrate Suc-LLVY-MCA (0.1 mM) with or
Table 1 Estimated contents of L-valine, L-leucine, and L-
isoleucine in experimental diets (g/kg diet)
Diet Valine (g/kg) Leucine (g/kg) Isoleucine (g/kg)
SLD 14 21 12
HVLID 46 50 44
HLD 13 120 11
SLD standard laboratory diet; HVLID diet with high content of valine, leucine,
and isoleucine; HLD high leucine diet
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without inhibitor MG132 (0.02 mM) for 1 h on ice. A
volume of 0.4 ml of 100 mM sodium acetate buffer
(pH 4.3) was added to stop the reaction. Sample fluores-
cence was immediately determined at an excitation
wavelength of 340 nm and emission wavelength of
440 nm (Tecan InfiniteTM 200). The standard curve was
established for 7-amino-4-methylcoumarin (AMC),
which permitted the expression of CHTLA as nmol of
AMC/g protein/hour. The activity was adjusted for the
protein concentration of the supernatant. Differences
after the subtraction of inhibited from non-inhibited ac-
tivities were used for calculations.
Cathepsin B and L activities
The activities of cathepsin B and L were determined
using the fluorogenic substrate Z-FA-MCA [25, 26] as
follows. Tissue samples (approximately 20 mg) were
homogenised in 0.6 ml of ice-cold 300 mM sodium acet-
ate buffer, pH 5.0, containing 4 mM EDTA, 8 mM di-
thiothreitol and 0.2 % Triton X-100 (v/v). The
homogenates were allowed to stand for 30 min on ice
and centrifuged for 30 min at 18,000 g at 4 °C. Cellular
supernatant (0.01 ml) were incubated with 0.19 ml of
substrate Z-FA-MCA (0.1 mM) with or without the in-
hibitor Z-FF-FMK (0.04 mM) for 30 min at 37 °C. The
reaction was stopped by the addition of 1 ml of 100 mM
sodium acetate buffer, pH 4.3, and the activities of ca-
thepsin B and L were determined as described above for
CHTLA.
Other techniques
Glutamine synthetase activity was determined using
a colorimetric assay based on the formation of γ-
glutamyl-hydroxamate [27]. The catalytic concentra-
tion of alanine aminotransferase was determined
from the rate of decrease of NADH, measured at
340 nm, by lactate dehydrogenase [28]. Enzyme ac-
tivities are reported per milligram of protein of reac-
tion mixture. Plasma levels of urea, creatinine, ALT,
AST, glucose, triglycerides, and cholesterol were
measured using commercial tests (Boehringer, Mann-
heim, Germany; Elitech, Sées, France and Lachema,
Brno, CR).
Statistics
Results are expressed as means ± SE. Analysis of vari-
ance (ANOVA) followed by Bonferroni multiple com-
parison post hoc analysis was used to detect
differences between multiple independent groups.
NCSS 2001 statistical software (Kaysville, UT, USA)
was used for analyses. Differences were considered
significant at P < 0.05.
Results
Effects of HVLID and HLD on food intake, body weight
and blood biochemistry
The intake of HVLID was lower than the intake of SLD
and HLD in the initial phase of the study. Differences in
daily food intake were not significant beginning the sec-
ond week. There were no differences in body weight
gain between animals receiving the various diets (Fig. 2).
Higher blood plasma concentrations of urea were ob-
served in animals that chronically consumed HVLID or
HLD. In HLD fed animals we observed higher ALT ac-
tivity and lower concentration of LDL cholesterol and
atherogenicity index than in controls (Table 2).
Effects of HVLID and HLD on amino acid and BCKA
concentrations in blood plasma
Plasma concentrations of BCAA, BCKA, alanine, and
glutamine increased significantly in animals fed HVLID.
Enhanced concentrations of leucine, KIC, glutamine and
alanine were also found in animals fed HLD, but con-
centrations of valine, isoleucine, KIV and KMV were sig-
nificantly lower than controls. Overnight starvation
decreased the plasma concentration of most amino acids
in controls and normalised alterations induced by the in-
take of HVLID or HLD (Table 3 and Fig. 3).
Effects of HVLID and HLD on amino acid concentrations
in tissues
HVLID increased levels of valine, leucine, and isoleucine
and HLD increased leucine and decreased valine and
isoleucine concentrations in all muscle types (Table 4).
In other tissues the effects of HVLID and HLD were less
significant (Table 5). Alanine concentrations were higher
in all muscle types of animals that consumed HVLID or
HLD and in the jejunum and kidneys of animals that
consumed HLD. Glutamine concentrations increased
significantly only in muscles of the HLD group. Most of
the alterations in intracellular amino acid concentrations
that were induced by the chronic intake of HVLID or
HLD in the postprandial state disappeared after an over-
night fast.
Effects of HVLID and HLD on glutamine synthetase and
alanine aminotransferase activities
The effect of chronic HVLID or HLD consumption on
glutamine synthetase and alanine aminotransferase in
muscles was not significant. Overnight starvation had no
effect on glutamine synthetase, but a significant increase
in alanine aminotransferase activity in muscles was
found in the SOL and MG of animals fed various diets
and the EDL of animals fed SLD before an overnight fast
(Figs. 4 and 5).
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Effects of HVLID and HLD on protein synthesis
The fractional rate of protein synthesis (Fig. 6) was
higher in the postprandial state in MG and SOL of ani-
mals fed an HVLID and in the jejunum of animals fed
an HLD. A decrease in protein synthesis was found in
muscles after an overnight fast. The decrease was more
pronounced in gastrocnemius muscles of animals that
consumed HVLID and in EDL muscles of animals that
consumed HLD. Higher values of protein synthesis were
observed in the postabsorptive state in the kidneys of
HVLID and HLD groups compared to controls.
Effects of HVLID and HLD on protein breakdown
Consumption of HVLID decreased CHTLA activities in
the muscles; HLD decreased CHTLA activities in the
muscles, liver, jejunum, and kidneys (Fig. 7). Cathepsin B
and L activities (Table 6) increased in the jejunum of the
HVLID group. Lower activities were found in the SOL
and jejunum of animals that consumed HLD compared
to animals fed by HVLID. Effect of HVLID and HLD on
CHTLA in muscles in postabsorptive state was insignifi-
cant. Cathepsin B and L activities in the jejunum and
EDL of HVLID and HLD groups were lower than con-
trols fed SLD before an overnight fast.
Effects of HVLID and HLD on weight and protein content
of tissues
The effect of HVLID on muscle weight and protein con-
tent was not significant, but lower weight and protein
content was found in EDL of animals that consumed
HLD. Chronic intake of HVLID and HLD significantly
increased the weight and protein content of the kidneys.
Fig. 2 Food intake and body weight changes in rats fed an SLD, HVLID and HLD. Means ± SE, p ˂ 0.05. *compared to the SLD group; † HLD group
vs. HVLID group
Table 2 Changes in blood plasma
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n = 10) HVLID + S (n = 10) HLD + S (n = 10)
Glucose (mmol/l) 9.67 ± 0.21 chylosity 8.58 ± 0.29 a 7.17 ± 0.18 b 8.84 ± 0.28 a 7.96 ± 0.24
Urea (mmol/l) 7.32 ± 0.21 9.60 ± 0.14 a 8.86 ± 0.32 a 6.31 ± 0.25 b 8.23 ± 0.24 a,b 9.00 ± 0.36 a
Creatinine (μmol/l) 27.9 ± 1.0 29.4 ± 1.1 27.6 ± 0.6 30.2 ± 1.3 30.9 ± 1.7 29.9 ± 0.85
ALT (μkat/l) 0.88 ± 0.05 0.97 ± 0.06 1.22 ± 0.03 a,c 0.68 ± 0.04 b 0.59 ± 0.05 a 0.86 ± 0.06 a,b,c
AST (μkat/l 1.35 ± 0.15 1.33 ± 0.05 1.16 ± 0.06 1.26 ± 0.05 1.29 ± 0.06 1.15 ± 0.05
Cholesterol (mmol/l) 1.64 ± 0.11 1.49 ± 0.08 1.54 ± 0.12 1.42 ± 0.10 1.47 ± 0.06 1.30 ± 0.07
HDL cholesterol (mmol/l) 1.08 ± 0.12 0.99 ± 0.04 1.31 ± 0.10 c 1.24 ± 0.09 1.02 ± 0.04 1.16 ± 0.07
LDL cholesterol (mmol/l) 0.29 ± 0.03 chylosity 0.17 ± 0.03 a 0.20 ± 0.03 b 0.28 ± 0.02 0.12 ± 0.01 c
Atherogenicity index 0.39 ± 0.03 0.51 ± 0.05 a 0.19 ± 0.02 a,c 0.14 ± 0.02 b 0.47 ± 0.03 a 0.12 ± 0.02 c
Triglycerides (mmol/l) 1.25 ± 0.07 0.72 ± 0.08 a 0.95 ± 0.06 0.79 ± 0.10 b 0.60 ± 0.07 0.86 ± 0.11
Total protein (g/l) 63.1 ± 0.7 63.0 ± 0.7 64.6 ± 1.2 58.0 ± 0.6 b 61.4 ± 0.8 a 60.3 ± 0.7 b
Albumins (mmol/l) 35.3 ± 1.4 34.7 ± 1.1 35.7 ± 1.8 33.1 ± 0.8 34.8 ± 1.6 33.7 ± 1.2
Means ± SE, p ˂ 0.05
SLD standard laboratory diet; SLD + S rats fed SLD starved overnight before sacrifice; HVLID diet with high content of valine, leucine, and isoleucine; HVLID + S rats
fed HVLID starved overnight before sacrifice; HLD high leucine diet; HLD + S rats fed HLD starved overnight before sacrifice
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Atherogenicity index was calculated as: (cholesterol-HDL cholesterol)/HDL cholesterol
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We also observed higher liver weights in HLD fed ani-
mals (Table 7).
Discussion
Only moderate changes in food intake and body weight
gain were observed between animals that consumed
various diets in the initial phase of our study. Therefore,
alterations in food intake did not affect our findings, but
food composition, i.e., the replacement of 10 % of the
basal diet with BCAAs or leucine alone exerted signifi-
cant effects.
Effects on amino acid concentration and metabolism
It is well established that the rate of BCAA degradation
in skeletal muscle is highly responsive to changes in diet-
ary intake. The Km of BCAA aminotransferases for
BCAAs is two- to four-fold higher than tissue BCAA
concentrations [29]. Therefore, the rate of transamin-
ation leading to the production of glutamate and BCKA
responds rapidly to changes in BCAA level. BCKA de-
hydrogenase activity in skeletal muscle is low, and most
BCKA that is produced in muscle is released to the cir-
culation and utilised in other tissues, especially the liver.
The rise in plasma levels of all three BCKAs and ketoi-
socaproate in animals fed HVLID and HLD, respectively,
indicates an enhanced load of these keto-acids in visceral
tissues with unknown consequences. Enhanced KIC pro-
duction from leucine may activate alternative pathways
of KIC (ketoleucine) catabolism by the cytosolic enzyme
KIC-dioxygenase in the liver. The result is an enhanced
synthesis of ß-hydroxy-ß-methylbutyrate, which may be
involved in the observed decrease in LDL cholesterol
and muscle protein breakdown in animals fed HLD [30,
31].
To determine whether adaptive changes in enzyme ac-
tivities in muscle tissue were involved in the rise in ala-
nine and glutamine in blood plasma, alanine
aminotransferase and glutamine synthetase activities
Table 3 Amino acid concentrations (μmol/l) in blood plasma
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n =10) HVLID + S (n = 10) HLD + S (n = 10)
Asp 17 ± 1 34 ± 3 a 25 ± 3 11 ± 1 26 ± 3 a 24 ± 6 a
Glu 129 ± 8 111 ± 6 108 ± 4 101 ± 6 129 ± 11 128 ± 10
Ser 254 ± 12 239 ± 4 217 ± 6 a 241 ± 8 232 ± 7 236 ± 7
Asn 70 ± 4 78 ± 2 64 ± 2 c 59 ± 2 b 67 ± 2 b 64 ± 2
Gly 306 ± 23 219 ± 6 a 191 ± 10 a 392 ± 15 b 319 ± 12 a,b 281 ± 10 a,b
Gln 713 ± 25 825 ± 12 a 808 ± 19 a 623 ± 10 b 678 ± 16 b 690 ± 14 a,b
His 66 ± 3 65 ± 2 57 ± 1 a,c 54 ± 2 b 56 ± 1 b 54 ± 2
Tau 324 ± 16 467 ± 50 437 ± 52 227 ± 17 528 ± 57 a 520 ± 31 a
Thr 284 ± 17 206 ± 6 a 206 ± 5 a 232 ± 14 b 230 ± 7 226 ± 6
Ctr 82 ± 4 87 ± 3 79 ± 3 60 ± 2 b 74 ± 2 a,b 69 ± 2
Ala 527 ± 27 667 ± 25 a 627 ± 13 a 364 ± 16 b 379 ± 12 b 412 ± 14 b
Arg 188 ± 9 175 ± 5 165 ± 6 a 150 ± 3 b 165 ± 5 157 ± 4
Pro 262 ± 16 251 ± 7 244 ± 6 131 ± 5 b 147 ± 3 b 140 ± 3 b
Tyr 94 ± 15 77 ± 3 a 71 ± 2 a 89 ± 3 85 ± 3 83 ± 3 b
Cys 123 ± 5 122 ± 2 106 ± 3 123 ± 3 138 ± 5 126 ± 5 b
Val 262 ± 8 444 ± 30 a 158 ± 6 a,c 213 ± 7 213 ± 4 b 206 ± 6
Met 63 ± 3 63 ± 1 56 ± 1 a 55 ± 1 b 52 ± 1 b 52 ± 1
Orn 67 ± 3 68 ± 5 69 ± 3 44 ± 2 b 52 ± 2 b 48 ± 2 b
Lys 339 ± 5 332 ± 9 324 ± 13 334 ± 9 417 ± 13 b 440 ± 11 b
Ile 135 ± 19 227 ± 21 a 91 ± 9 a,c 122 ± 6 122 ± 2 b 134 ± 9 b
Leu 228 ± 18 317 ± 21 a 543 ± 35 a.c 177 ± 7 195 ± 4 b 189 ± 6 b
Phe 72 ± 3 71 ± 1 73 ± 1 69 ± 2 72 ± 2 70 ± 2
BCAA 625 ± 37 988 ± 71 a 793 ± 40 a,c 513 ± 20 530 ± 9 b 529 ± 20 b
∑ - BCAA 3975 ± 151 4157 ± 87 3928 ± 94 3361 ± 86 b 3846 ± 75 a 3819 ± 74 a
Means ± SE, p ˂ 0.05
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Abbreviations as indicated in Table 1
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were measured in muscles. Although marked alterations
have been reported in various conditions, such dexa-
methasone treatment [27], chronic consumption of
HVLID and HLD was without notable adaptive changes
in these enzymes. Therefore, the main mechanism
leading to enhanced alanine and glutamine production
in skeletal muscle should be an increased flux of glutam-
ate through glutamine synthetase and alanine amino-
transferase resulting from enhanced glutamate
production by BCAA aminotransferase.
A chronically enhanced release of BCKA, alanine, and
glutamine from muscle may be related to the observed
hypertrophy of the kidneys. Enhanced glutamine load
may activate ammonia production in various tissues, es-
pecially gut and kidneys, and in the case of impaired am-
monia detoxification to urea in liver disease induce
symptoms of hepatic encephalopathy [32]. Enhanced
ammonia concentrations in blood after BCAA supple-
mentation were found during exercise and following a
leucine intake >500 mg⋅kg-1⋅d-1 [33, 34]. Nevertheless,
alterations in aminoacidemia induced by BCAA intake
may also have favourable effects. The example might be
positive influence of glutamine on the immune system,
protein balance, and gut integrity.
The drop in concentrations of valine and isoleucine in
blood plasma and muscles in animals fed high amounts
of leucine is likely due to the well-known phenomenon
that is referred to as BCAA antagonism [35]. Leucine
stimulates the BCKA dehydrogenase complex that con-
trols the rate limiting step in BCAA catabolism leading
to enhanced catabolism of all three BCAAs. Depletion of
Table 4 Amino acid concentrations in muscles (μmol/l of intracellular water)
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n =10) HVLID + S (n = 10) HLD + S (n = 10)
M. gastrocnemius
Valine 269 ± 15 547 ± 28 a 166 ± 8 a,c 317 ± 9 352 ± 10 b 336 ± 19 b
Isoleucine 129 ± 10 227 ± 12 a 72 ± 5 a,c 182 ± 5 b 199 ± 5 181 ± 8 b
Leucine 193 ± 13 328 ± 19 a 533 ± 30 a,c 264 ± 7 b 302 ± 10 304 ± 18 b
Glutamine 5773 ± 244 5731 ± 212 6665 ± 236 a,c 3870 ± 141 b 3892 ± 148 b 4714 ± 103 a,b,c
Alanine 3188 ± 165 4838 ± 644a 4879 ± 183 a 3227 ± 103 3025 ± 61 b 3467 ± 115 b
M. soleus
Valine 190 ± 8 452 ± 26 a 128 ± 9 a,c 229 ± 9 226 ± 6 b 215 ± 11 b
Isoleucine 92 ± 6 184 ± 12 a 49 ± 6 a,c 126 ± 5 b 116 ± 3 b 109 ± 6 b
Leucine 159 ± 10 287 ± 15 595 ± 93 a,c 231 ± 19 196 ± 4 216 ± 12 b
Glutamine 12,374 ± 279 13,849 ± 451 15,137 ± 835 a 11,887 ± 357 11,962 ± 529 b 13,656 ± 334
Alanine 3293 ± 99 3920 ± 151 a 3972 ± 204 a 3633 ± 131 3558 ± 132 3854 ± 112
M. ext.digitorum longus
Valine 268 ± 9 552 ± 28 a 177 ± 7 a 336 ± 23 b 339 ± 8 b 330 ± 13 b
Isoleucine 124 ± 4 235 ± 12 a 82 ± 7 a,c 199 ± 12 b 194 ± 10 b 182 ± 13 b
Leucine 201 ± 8 354 ± 23 a 558 ± 27 a,c 297 ± 18 b 325 ± 38 b 297 ± 10 b
Glutamine 8413 ± 322 9216 ± 293 9935 ± 480 a 5880 ± 175 b 6137 ± 193 b 6838 ± 140 b
Alanine 3499 ± 136 4642 ± 111 a 5272 ± 235 a,c 3635 ± 143 3762 ± 115 b 3818 ± 110 b
Means ± SE, p ˂ 0.05
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Abbreviations as indicated in Table 1
Fig. 3 Branched-chain keto acids in blood plasma. Means ± SE, p ˂
0.05. *compared to the corresponding control (SLD or SLD + S); #
compared to the corresponding fed group; † HLD (HLD + S) group
vs. HVLID (HVLID + S) group. KIC: α-ketoisocaproate (ketoleucine),
KMV: α-keto-β-methylvalerate (ketoisoleucine), KIV:
α-ketoisovalerate (ketovaline)
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valine and isoleucine pools may also be due to their
competition with leucine for transport via the L-carrier
system.
Effects on protein metabolism in skeletal muscle
Higher protein synthesis rates and decreased CHTLA in
the postprandial state in the muscles of animals fed an
HVLID are consistent with most in vitro studies and/or
studies that assessed the immediate response to BCAA
administration [2, 36–38]. Therefore, our results confirm
the regulatory effects of BCAAs on protein turnover,
which may exert a positive influence on muscle protein
balance. The marked decrease in CHTLA in muscles of
animals fed an HLD is consistent with studies that
Table 5 Amino acid concentrations in liver, jejunum, and kidneys (μmol/l of intracellular water)
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n =10) HVLID + S (n = 10) HLD + S (n = 10)
Live
Valine 430 ± 26 946 ± 51 a 438 ± 26 c 449 ± 31 469 ± 32 b 514 ± 25
Isoleucine 692 ± 65 555 ± 33 a 321 ± 13 a,c 308 ± 27 b 280 ± 19 b 307 ± 18
Leucine 603 ± 57 861 ± 50 1663 ± 158 a 545 ± 35 534 ± 38 b,c 580 ± 32 b
Glutamine 15,588 ± 308 15,253 ± 646 14,247 ± 749 15,644 ± 1006 16,574 ± 1052 18,694 ± 639 a,b
Alanine 6927 ± 340 6778 ± 321 6618 ± 335 3096 ± 378 b 3371 ± 362 b 4973 ± 224 a,b,c
Jejunum
Valine 725 ± 75 1528 ± 195 a 918 ± 53 c 632 ± 94 569 ± 48 562 ± 42
Isoleucine 477 ± 51 990 ± 146 a 634 ± 47 c 406 ± 61 357 ± 34 357 ± 30
Leucine 790 ± 73 1589 ± 215 3367 ± 644 a,c 787 ± 109 623 ± 57 718 ± 48
Glutamine 1900 ± 202 1721 ± 148 1871 ± 149 1042 ± 79 b 1358 ± 102 1456 ± 105
Alanine 6032 ± 431 6036 ± 233 7338 ± 249 a,c 4107 ± 308 4495 ± 182 4,5003 ± 202
Kidney
Valine 402 ± 33 675 ± 51 a 410 ± 34 c 404 ± 21 444 ± 26 444 ± 21
Isoleucine 308 ± 35 344 ± 27 295 ± 51 222 ± 11 239 ± 15 241 ± 17
Leucine 481 ± 33 503 ± 37 911 ± 73 a,c 481 ± 20 241 ± 80 b 483 ± 28 b
Glutamine 4335 ± 193 4051 ± 123 4110 ± 312 3233 ± 216 b 3249 ± 197 3324 ± 133 b
Alanine 2156 ± 84 2331 ± 132 2801 ± 113 a,c 1719 ± 81 b 1857 ± 63 b 2109 ± 64 b
Means ± SE, p ˂ 0.05
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Abbreviations as indicated in Table 1
Fig. 4 Glutamine synthetase. Means ± SE, p ˂ 0.05. *compared to the
corresponding control (SLD or SLD + S); # compared to the
corresponding fed group; † HLD (HLD + S) group vs. HVLID
(HVLID + S) group
Fig. 5 Alanine aminotransferase. Means ± SE, p ˂ 0.05. *compared to
the corresponding control (SLD or SLD + S); # compared to the
corresponding fed group; † HLD (HLD + S) group vs. HVLID
(HVLID + S) group
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concluded that leucine administration may specifically
induce a reduction in protein breakdown without in-
creasing protein synthesis [39–41]. However, we failed to
demonstrate a positive effect of BCAA on muscle pro-
tein balance and a negative effect in EDL muscles
exerted chronic consumption of excessive amounts of
leucine. This was indicated by insignificant changes in
weight and protein content in muscles of animals con-
suming HVLID and the decrease in EDL muscles in the
HLD group.
We suppose that the discrepancy between the positive
effects of HVLID on protein synthesis and proteolysis
and HLD on proteolysis and the insignificant changes in
muscle protein content may be explained by metabolic
alterations in the postabsorptive state that were induced
in our study by an overnight fast. Decreased rates of
protein synthesis and CHTLA activities in overnight-
fasted animals fed a normal diet represent metabolic
adaptation that spares muscle protein in starvation. The
more pronounced decrease in protein synthesis
gastrocnemius muscles in HVLID group and in EDL
muscles in HLD group of overnight-starved animals in-
dicate an impaired metabolic response that is clearly not
beneficial for muscle protein balance.
The adverse effect of a leucine-enriched diet is
likely related to decreased intracellular pools of valine
and isoleucine and preferential leucine oxidation. Both
valine and isoleucine catabolites may be utilised in
the citric cycle and promote consumption of pyruvate
from glycolysis while the end product of leucine is
acetyl Co-A, which blocks the entry of pyruvate into
the citric cycle. Therefore, preferential leucine oxida-
tion may exert negative effect on glycolysis, ATP pro-
duction, and muscle performance, and lead to
elevations in alanine aminotransferase activities in
blood plasma. Enhanced plasma alanine aminotrans-
ferase activity without alterations in other markers of
hepatocellular damage was reported after dietary leu-
cine excess in muscle disease patients and apparently
healthy individuals [42–44].
Fig. 6 Fractional rate of protein synthesis. Means ± SE, p ˂ 0.05. *compared to the corresponding control (SLD or SLD + S); # compared to the
corresponding fed group; † HLD (HLD + S) group vs. HVLID (HVLID + S) group
Fig. 7 Chymotrypsin-like activity. Means ± SE, p ˂ 0.05. *compared to the corresponding control (SLD or SLD + S); #compared to the
corresponding fed group; † HLD (HLD + S) group vs. HVLID (HVLID + S) group
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The finding of more significant alterations in EDL
muscles compared to SOL or gastrocnemius muscles
presents additional evidence that muscles composed
mostly of white, fast-twitch fibres are more sensitive to
various physiological or pathological signals than mus-
cles composed mostly of red, slow-twitch fibres [45, 46].
A number of variables can modify the response to
starvation, e.g., duration of starvation, muscle type, and
ageing. Combaret et al. [47] reported that the rates of
proteasome-dependent proteolysis were 1.5–2 fold
higher in muscles in postabsorptive state and that with
aging tended to decrease in the postabsorptive state and
Table 6 Cathepsin B and L activities (nmol AMC/mg protein/hour)
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n =10) HVLID + S (n = 10) HLD (n = 10)
M. gastrocnemius 5.4 ± 1.1 4.3 ± 1.6 5.7 ± 1.2 6.5 ± 1.4 6.0 ± 0.9 5.9 ± 1.1
M. soleus 44.3 ± 2.6 51.4 ± 3.2 39.0 ± 2.1 c 55.4 ± 3.8 b 45.4 ± 1.6 27.4 ± 2.1 a,b,c
M. ext. digitorum longus 12.6 ± 1.4 11.5 ± 1.4 8.0 ± 1.4 10.1 ± 4.7 4.7 ± 1.6 a,b 1.6 ± 1.0 a,b
Liver 213 ± 10 233 ± 11 192 ± 12 346 ± 21 b 394 ± 14 b 372 ± 16 b
Jejunum 164 ± 7 214 ± 17 a 98 ± 24 c 270 ± 20 104 ± 16 a,b 99 ± 23 a
Kidney 1420 ± 47 1337 ± 96 831 ± 56 1566 ± 50 1126 ± 56 1021 ± 57
Means ± SE, p ˂ 0.05
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Abbreviations as indicated in Table 1
Table 7 Tissue weights, protein concentration, and protein content.
Fed animals Overnight starved animals
SLD (n = 10) HVLID (n = 10) HLD (n = 9) SLD + S (n =10) HVLID + S (n = 10) HLD + S (n = 10)
M. gastrocnemius
- Weight (g/kg b.w.) 4.16 ± 0.20 4.45 ± 0.21 4.09 ± 0.23 4.67 ± 0.67 4.69 ± 0.12 4.29 ± 0.14
- Protein (mg/g) 240 ± 8 234 ± 8 231 ± 5 233 ± 6 245 ± 7 238 ± 6
- Protein (mg/kg b.w.) 996 ± 58 1047 ± 72 946 ± 56 1088 ± 56 1144 ± 30 1027 ± 57
M. soleus
- Weight (g/kg b.w.) 0.43 ± 0.01 0.48 ± 0.02 0.40 ± 0.01 c 0.49 ± 0.01 b 0.51 ± 0.01 0.42 ± 0.01 a,c
- Protein (mg/g) 223 ± 14 218 ± 7 228 ± 11 225 ± 4 241 ± 5 243 ± 10
- Protein (mg/kg b.w.) 97 ± 3 104 ± 4 91 ± 6 110 ± 3 122 ± 5 b 102 ± 6 c
M. ext. digitorum longus
- Weight (g/kg b.w.) 0.42 ± 0.01 0.43 ± 0.01 0.39 ± 0.00 a,c 0.45 ± 0.01 0.45 ± 0.01 0.41 ± 0.01 a,c
- Protein (mg/g) 271 ± 7 251 ± 6 272 ± 7 279 ± 8 262 ± 11 266 ± 8
- Protein (mg/kg b.w.) 114 ± 5 109 ± 4 97 ± 3 a 127 ± 4 118 ± 5 109 ± 3 a
Liver
- Weight (g/kg b.w.) 35.87 ± 1.05 37.35 ± 0.68 39.35 ± 0.80 a 27.36 ± 0.49 b 26.96 ± 0.64 b 30.07 ± 0.7 b,c
- Protein (mg/g) 244 ± 8 242 ± 6 240 ± 8 320 ± 9 b 270 ± 6 a,b 278 ± 8 a,b
- Protein (mg/kg b.w.) 8780 ± 462 9010 ± 235 9434 ± 386 8718 ± 190 7272 ± 184 b,c 8350 ± 293
Jejunum
- Protein (mg/g) 197 ± 7 181 ± 8 176 ± 5 199 ± 9 179 ± 12 166 ± 6
Kidney
- Weight (g/kg b.w.) 3.21 ± 0.13 3.56 ± 0.07 a 3.61 ± 0.10 a 3.18 ± 0.07 3.53 ± 0.09 a 3.44 ± 0.07 a
- Protein (mg/g) 222 ± 8 229 ± 9 222 ± 4 213 ± 7 221 ± 5 222 ± 6
- Protein (mg/kg b.w.) 709 ± 28 815 ± 32 a 798 ± 19 a 674 ± 24 774 ± 9 a 761 ± 18 a
Means ± SE, p ˂ 0.05
a compared to the corresponding control (SLD or SLD + S)
b compared to the corresponding fed group
c HLD (HLD + S) vs. HVLID (HVLID + S). Abbreviations as indicated in Table 1
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increase in the postprandial state. A role may play alter-
ations in insulin sensitivity, the BCKA dehydrogenase activ-
ity, and amino acid concentrations [35, 48]. It should be
noted that only protein synthesis rates can be measured dir-
ectly under in vivo conditions. Proteolysis can be estimated
indirectly, e.g. by changes MuRF1 and MAFbx expression,
rates of ubiquitination, and activities of enzymes of
ubiquitin-proteasome system [49]. Therefore, the results of
the present study cannot exclude significant effects of
chronic consumption of HVLID or HLD on proteolysis in
postabsorptive state in other experimental conditions.
Conclusions
To the best of our knowledge, this report is the first study
to assess the metabolic response to BCAA and leucine sup-
plementation in postprandial and postabsorptive states. We
conclude that the chronic intake of a BCAA- or leucine-
enriched diet significantly affects whole body metabolism
as demonstrated by alterations in urea, alanine aminotrans-
ferase, and LDL cholesterol in blood, protein synthesis and
proteolysis in various tissues, amino acid concentrations in
blood and tissues, and liver and kidney weights. However,
the results failed to demonstrate positive effects of the
chronic consumption of BCAA or leucine-enriched diets
on protein balance in skeletal muscle.
The non-significant effect of HVLID and rather negative
effect of HLD on protein balance may be explained by de-
pletion of valine and isoleucine pools in animals fed by an
HLD and an impaired response to short-term starvation,
which was characterised by impaired synthesis of muscle
proteins, particularly in muscles with high content of white,
fast-twitch fibres. These findings explain the discrepancy
between the protein anabolic effects of BCAA or leucine
on muscles that were reported under in vitro conditions
and/or shortly after BCAA intake [2, 36–38] and their re-
duced or lack of effects following chronic administration
[15, 50–52].
It should be noted that the present study was per-
formed in healthy individuals without the adverse effects
of signals that occur in several disorders, which lead to
muscle wasting, and without the stimulatory effect of ex-
ercise on signalling pathways that activate protein syn-
thesis. Further research is needed into the effects of
chronic BCAA and leucine consumption in muscle-
wasting disorders, the elderly, and during endurance
exercise.
Abbreviations
AMC: 7-Amino-4-methylcoumarin; BCAA: Branched-chain amino acids (valine,
leucine, and isoleucine); BCKA: Branched-chain keto acids;
CHTLA: Chymotrypsin-like activity; FRPS: Fractional rate of protein synthesis;
HLD: High leucine diet; HLD + S: Rats fed HLD starved overnight before
sacrifice; HVLID: Diet with high content of valine, leucine, and isoleucine;
HVLID + S: Rats fed HVLID starved overnight before sacrifice; KIC: α-
Ketoisocaproate (ketoleucine); KMV: α-Keto-β-methylvalerate (ketoisoleucine);
KIV: α-Ketoisovalerate (ketovaline); SLD: Standard laboratory diet; SLD + S: Rats
fed SLD starved overnight before sacrifice.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
MH outlined the experiments, performed statistical analysis, and prepared
the draft of the manuscript. MV, PS and RK were involved in data acquisition
and their interpretation. All authors read and approved the final manuscript.
Acknowledgements
The authors wish to thank to R. Fingrova, L. Kriesfalusyova, and D. Jezkova for
their technical assistance.
Funding
This project was supported by the program PRVOUK P37/02.
Author details
1Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles
University in Prague, Simkova 870, Hradec Kralove 500 38, Czech Republic.
2Department of Biochemistry, Faculty of Medicine in Hradec Kralove, Charles
University Prague, Hradec Kralove, Czech Republic. 3Department of Biological
and Biochemical Sciences, Faculty of Chemical Technology, University of
Pardubice, Pardubice, Czech Republic.
Received: 9 November 2015 Accepted: 5 February 2016
References
1. Fulks RM, Li JB, Goldberg AL. Effects of insulin, glucose, and amino acids on
protein turnover in rat diaphragm. J Biol Chem. 1975;250:290–8.
2. Buse MG, Reid SS. Leucine. A possible regulator of protein turnover in
muscle. J Clin Invest. 1975;56:1250–61.
3. Li JB, Jefferson LS. Influence of amino acid availability on protein turnover in
perfused skeletal muscle. Biochim Biophys Acta. 1978;544:351–9.
4. Garlick PJ. The role of leucine in the regulation of protein metabolism.
J Nutr. 2005;135:1553S–6S.
5. Nair KS, Short KR. Hormonal and signaling role of branched-chain amino
acids. J Nutr. 2005;135:1547S–52S.
6. Tischler ME, Desautels M, Goldberg AL. Does leucine, leucyl-tRNA, or some
metabolite of leucine regulate protein synthesis and degradation in skeletal
and cardiac muscle? J Biol Chem. 1982;257:1613–21.
7. Holecek M, Muthny T, Kovarik M, Sispera L. Effect of beta-hydroxy-beta-
methylbutyrate (HMB) on protein metabolism in whole body and in
selected tissues. Food Chem Toxicol. 2009;47:255–9.
8. Ruderman NB, Berger M. The formation of glutamine and alanine in skeletal
muscle. J Biol Chem. 1974;249:5500–6.
9. Odessey R, Goldberg AL. Oxidation of leucine by rat skeletal muscle.
Am J Physiol. 1972;223:1376–83.
10. Durschlag RP, Smith RJ. Regulation of glutamine production by skeletal
muscle cells in culture. Am J Physiol. 1985;248:C442–8.
11. Yang Q, Birkhahn RH. Branched-chain transaminase and keto acid
dehydrogenase activities in burned rats: evidence for a differential
adaptation according to sex. Nutrition. 1997;13:640–5.
12. Hickson RC, Wegrzyn LE, Osborne DF, Karl IE. Glutamine interferes with
glucocorticoid-induced expression of glutamine synthetase in skeletal
muscle. Am J Physiol. 1996;270:E912–7.
13. Holecek M, Sispera L. Glutamine deficiency in extracellular fluid exerts
adverse effects on protein and amino acid metabolism in skeletal muscle of
healthy, laparotomized, and septic rats. Amino Acids. 2014;46:1377–84.
14. Elango R, Chapman K, Rafii M, Ball RO, Pencharz PB. Determination of the
tolerable upper intake level of leucine in acute dietary studies in young
men. Am J Clin Nutr. 2012;96:759–67.
15. Tsubuku S, Hatayama K, Katsumata T, Nishimura N, Mawatari K, Smriga M,
et al. Thirteen-week oral toxicity study of branched-chain amino acids in
rats. Int J Toxicol. 2004;23:119–26.
16. Mawatari K, Katsumata T, Uematsu M, Katsumata T, Yoshida J, Smriga M,
et al. Prolonged oral treatment with an essential amino acid L-leucine does
not affect female reproductive function and embryo-fetal development in
rats. Food Chem Toxicol. 2004;42:1505–11.
Holecek et al. Nutrition & Metabolism  (2016) 13:12 Page 11 of 12
17. Garlick PJ, McNurlan MA, Preedy VR. A rapid and convenient technique for
measuring the rate of protein synthesis in tissue by injection of
[3H]phenylalanine. Biochem J. 1980;192:719–23.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with
the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
19. McNurlan MA, Tomkins AM, Garlick PJ. The effect of starvation on the rate
of protein synthesis in rat liver and small intestine. Biochem J. 1979;178:
373–9.
20. Welle S. Methods for studying protein metabolism in humans. In: Human
protein metabolism. New-York: Springer; 1999. p. 29–71.
21. Bergström J, Fürst P, Norée LO, Vinnars E. Intracellular free amino acid
concentration in human muscle tissue. J Appl Physiol. 1974;36:693–7.
22. Graham JA, Lamb JF, Linton AL. Measurement of body water and
intracellular electrolytes by means of muscle biopsy. Lancet. 1976;2(7527):
1172–6.
23. Kandar R, Zakova P, Jirosova J, Sladka M. Determination of branched chain
amino acids, methionine, phenylalanine, tyrosine and α-keto acids in plasma
and dried blood samples using HPLC with fluorescence detection. Clin
Chem Lab Med. 2009;47:565–72.
24. Gomes-Marcondes MCC, Tisdale MJ. Induction of protein catabolism and
the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett.
2002;180:69–74.
25. Koohmaraie M, Kretchmar DH. Comparisons of four methods for
quantification of lysosomal cysteine proteinase activities. J Anim Sci. 1990;
68:2362–70.
26. Tardy C, Autefage H, García V, Levade T, Andrieu-Abadie N. Mannose 6-
phosphorylated proteins are required for tumor necrosis factor-induced
apoptosis: defective response in I-cell disease fibroblasts. J Biol Chem. 2004;
279:52914–23.
27. Minet R, Villie F, Marcollet M, Meynial-Denis D, Cynober L. Measurement of
glutamine synthetase activity in rat muscle by a colorimetric assay. Clin
Chim Acta. 1997;268:121–32.
28. Gella FJ, Olivella T, Cruz Pastor M, Arenas J, Moreno R, Durban R, et al. A
simple procedure for the routine determination of aspartate
aminotransferase and alanine aminotransferase with pyridoxal phosphate.
Clin Chim Acta. 1985;153:241–7.
29. Krebs HA. Some aspects of the regulation of fuel supply in omnivorous
animals. Adv Enzyme Regul. 1972;10:397–420.
30. Nissen S, Sharp RL, Panton L, Vukovich M, Trappe S, Fuller JC. Beta-hydroxy-
beta-methylbutyrate (HMB) supplementation in humans is safe and may
decrease cardiovascular risk factors. J Nutr. 2000;130:1937–45.
31. Kovarik M, Muthny T, Sispera L, Holecek M. Effects of β-hydroxy-β-
methylbutyrate treatment in different types of skeletal muscle of intact
and septic rats. J Physiol Biochem. 2010;66:311–9.
32. Holecek M. Branched-chain amino acids and ammonia metabolism in liver
disease: therapeutic implications. Nutrition. 2013;29:1186–91.
33. MacLean DA, Graham TE. Branched-chain amino acid supplementation
augments plasma ammonia responses during exercise in humans. J Appl
Physiol. 1993;74:2711–7.
34. Pencharz PB, Elango R, Ball RO. Determination of the tolerable upper intake
level of leucine in adult men. J Nutr. 2012;142:2220S–4S.
35. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism.
Annu Rev Nutr. 1984;4:409–54.
36. Mitch WE, Clark AS. Specificity of the effects of leucine and its metabolites
on protein degradation in skeletal muscle. Biochem J. 1984;222:579–86.
37. Lynch CJ, Hutson SM, Patson BJ, Vaval A, Vary TC. Tissue-specific effects of
chronic dietary leucine and norleucine supplementation on protein
synthesis in rats. Am J Physiol. 2002;283:E824–35.
38. Kobayashi H, Kato H, Hirabayashi Y, Murakami H, Suzuki H. Modulations of
muscle protein metabolism by branched-chain amino acids in normal and
muscle-atrophying rats. J Nutr. 2006;136:234S–6S.
39. Matthews DE. Observations of branched-chain amino acid administration in
humans. J Nutr. 2005;135:1580S–4S.
40. Louard RJ, Barrett EJ, Gelfand RA. Overnight branched-chain amino acid
infusion causes sustained suppression of muscle proteolysis. Metabolism.
1995;44:424–9.
41. Nair KS, Schwartz RG, Welle S. Leucine as a regulator of whole body and
skeletal muscle protein metabolism in humans. Am J Physiol. 1992;263:
E928–34.
42. Matsuzaki K, Kato H, Sakai R, Toue S, Amao M, Kimura T. Transcriptomics and
metabolomics of dietary leucine excess. J Nutr. 2005;135:1571S–5S.
43. Lott JA, Landesman PW. The enzymology of skeletal muscle disorders. Crit
Rev Clin Lab Sci. 1984;20:153–90.
44. Pertusi R, Dickerman RD, McConathy WJ. Evaluation of aminotransferase
elevations in a bodybuilder using anabolic steroids: hepatitis or
rhabdomyolysis? J Am Osteopath Assoc. 2001;101:391–4.
45. Kadlcikova J, Holecek M, Safranek R, Tilser I, Kessler BM. Effects of
proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein
metabolism in septic rats. Int J Exp Pathol. 2004;85:365–71.
46. Muthny T, Kovarik M, Sispera L, Tilser I, Holecek M. Protein metabolism in
slow- and fast-twitch skeletal muscle during turpentine-induced
inflammation. Int J Exp Pathol. 2008;89:64–71.
47. Combaret L, Dardevet D, Rieu I, Pouch MN, Béchet D, Taillandier D, et al. A
leucine-supplemented diet restores the defective postprandial inhibition of
proteasome-dependent proteolysis in aged rat skeletal muscle. J Physiol.
2005;569:489–99.
48. Khatra BS, Chawla RK, Wadsworth AD, Rudman D. Effect of dietary
branched-chain alpha-keto acids on hepatic branched-chain alpha-keto acid
dehydrogenase in the rat. J Nutr. 1977;107:1528–36.
49. Attaix D, Ventadour S, Codran A, Béchet D, Taillandier D, Combaret L. The
ubiquitin proteasome system and skeletal muscle wasting. Essays Biochem.
2005;41:173–86.
50. Mourier A, Bigard AX, de Kerviler E, Roger B, Legrand H, Guezennec CY.
Combined effects of caloric restriction and branched-chain amino acid
supplementation on body composition and exercise performance in elite
wrestlers. Int J Sports Med. 1997;18:47–55.
51. Spillane M, Emerson C, Willoughby DS. The effects of 8 weeks of heavy
resistance training and branched-chain amino acid supplementation on
body composition and muscle performance. Nutr Health. 2012;21:263–73.
52. Nelson AR, Phillips SM, Stellingwerff T, Rezzi S, Bruce SJ, Breton I, et al. A
protein-leucine supplement increases branched-chain amino acid and
nitrogen turnover but not performance. Med Sci Sports Exerc. 2012;44:57–68.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Holecek et al. Nutrition & Metabolism  (2016) 13:12 Page 12 of 12
